>> MOEHS will take part in the forthcoming exhibition of CPhI 2010
As usual every year, the group MOEHS will install booth at the annual event aimed at all manufacturers of APIs (active pharmaceutical ingredients) where meet the largest companies in the sector.
This year will be held in Paris on 5, 6 and 7 October. We will share the booth with sister companies PMC Group Europe (Benechim Sprl, Chemische Fabrik Berg GmbH Norchim SAS and Raschig GmbH).
It will be a pleasure to assist you all in Hall 6, Stand 6B18 where you will be informed about the range of our products and services
>> FDA inspection on Moehs Catalana,S.L.
Moehs Catalana S.L. was inspected by FDA (Food Drug Administration) last February 2010 regarding compliance with GMPs. At the end of the inspection a "Form FDA 483" was issued listing only three minor observations. We are awaiting the final EIR in short place.
As in previous audits of the FDA the results of that inspection has been fully satisfactory which motivates us and encourage us to continue maintaining our high standards of quality.
>> TGA audit in Moehs Cántabra,S.L.
Australian Health Authorities “TGA” (Therapeutic Goods Administration) re-audit last May 2010 our manufacturing plant Moehs Cántabra,S,L.
The TGA carries out a range of assessment and monitoring activities worldwide to ensure therapeutic goods available in Australia are of an acceptable standard with the aim of ensuring that the Australian community has access, within a reasonable time, to therapeutic advances.
In this second visit of the TGA to our plant we have to emphasize the good outcome of the checking also auditor certifies at the end of it our proper following Q7A ICH, GMP Guide for Active Pharmaceutical Ingredients.
